2020
Clinical and economic burden of neurofibromatosis type 2 in the United States
Koo AB, Yeung JT, Freedman IG, Lee JH, Ahmed OM, Ma AK, Miyagishima DF, DiLuna M, Kahle K. Clinical and economic burden of neurofibromatosis type 2 in the United States. Clinical Neurology And Neurosurgery 2020, 197: 106053. PMID: 32683193, DOI: 10.1016/j.clineuro.2020.106053.Peer-Reviewed Original ResearchConceptsOpen resectionPatient demographicsRisk factorsMeningioma resectionMulti-year cross-sectional studyNeurofibromatosis type 2 (NF2) patientsSpine tumor resectionCommon admission diagnosesNational Inpatient SampleType 2 patientsCross-sectional studySignificant independent associationNeurofibromatosis type 2Regression analysisInflation-adjusted costAdmission diagnosisHospital stayDischarge weightIndependent predictorsObstructive hydrocephalusSurgical interventionDiagnosis codesHospital characteristicsInpatient populationInpatient Sample
2014
Hemifacial Spasm and Neurovascular Compression
Lu AY, Yeung JT, Gerrard JL, Michaelides EM, Sekula RF, Bulsara KR. Hemifacial Spasm and Neurovascular Compression. The Scientific World JOURNAL 2014, 2014: 349319. PMID: 25405219, PMCID: PMC4227371, DOI: 10.1155/2014/349319.Peer-Reviewed Original ResearchConceptsHemifacial spasmMicrovascular decompressionMagnetic resonance imagingSymptomatic reliefFacial nerveNerve root entry zonePrimary hemifacial spasmSecondary hemifacial spasmBotulinum neurotoxin injectionStandard medical managementTreatment of choiceFacial nerve rootRoot entry zoneIpsilateral facial nerveFacial nerve damageFacial movement disordersHFS patientsNerve damageVascular compressionCurative treatmentMedical managementNerve rootsNeurovascular compressionSurgical interventionClinical examination